Obesity dominates as future blockbusters are identified

Two drug candidates targeting obesity and diabetes stand out sharply in Clarivate’s newly selected “starting eleven” of potential future blockbusters worth watching.

The Beauty of Clinical Microscopy of Urine Sediment

Read about concrete observations using phase contrast and polarized light.

Optical inspection made easy

New ZEISS Smartzoom 100 product video.

Ett år efter avbruten GPL-1-behandling – nästan hälften behöll sin vikt

Att avsluta medicinering med GLP‑1‑läkemedel behöver inte innebära att man går upp i vikt igen. I en stor amerikansk studie behöll nästan hälften av patienterna...

Collaboration across the Øresund – Camurus enters Danish licensing agreement

Lund‑based Camurus has entered into a collaboration and licensing agreement with Danish company Gubra, which specializes in peptide‑based drug development.

FDA’s new CSA guidance: transforming software validation for production and quality systems

FDA’s final guidance on Computer Software Assurance (CSA) for Production and Quality System Software marks a significant modernization of software validation practices.

Gothenburg-based Anyo Labs gains ground in the AI race

In a fifty-square-metre space in Gothenburg sits a company aiming to secure its place on one of the world's hottest technological stages: AI-driven drug develop...

From Image to Results

3D multiplexing spatial omics workflows in neuroscience.

“There’s no magic wand” – The urgent need for new treatments

One in ten women with recurrent yeast infections develops a stubborn, hard-to-treat condition for which no effective therapies currently exist. At Danderyd Hosp...

Enhancing Spatial Biology

Enabling easy, reproducible multiplex spatial profiling at scale.

”Vi behöver bli bättre på att skryta”

Sverige är starkt inom life science, men kan bli ännu starkare. Sweden Bios vd Jessica Martinsson efterlyser bättre politiska villkor och ett Sverige som vågar ...

Getinge and Neobiomics received Swecare's export awards

Two companies received awards during Swecare's annual conference.

Fourteen US-based top researchers recruited to Sweden

Sweden has set its sights on America’s top scholars – and it seems to work. By the end of 2025, fourteen leading U.S.-based researchers had already been won ove...

Shaping the Future of Metrology – Live in Your Region

Insights into our event series.

Acne medication may be the solution when hair starts falling out

A treatment originally developed for acne has shown remarkable Phase III results in a completely different area: male-pattern hair loss.

“Access to capital increases when there’s an exit”

It remains a tough environment for biotech companies seeking financing – but there is good reason to hope for improvement ahead. That’s the view of Okee William...

Gene therapies on clinical hold after tumour found in five‑year‑old

The development of a brain tumour in a study participant has led the FDA to temporarily halt two ongoing gene therapy programs. The affected company, Regenxbio,...

”Trickier than bacteria”: Why severe fungal infections are on the rise

There’s a reason Earth is sometimes called the planet of fungi. These ancient organisms – billions of years old and more closely related to animals than to plan...

Experience innovations of the future

ZEISS QUALITY INNOVATIONS WORLDWIDE event in Oberkochen, Germany, January 20-21, 2026.

Bioscience – Groundbreaking Research & Diagnostics: Stockholm

Positive outcome in phase III for Sanofi’s eczema treatment

The antibody amlitelimab shows positive Phase III data as a treatment for atopic dermatitis. France‑based Sanofi now plans to submit global regulatory applicati...

Southern Swedish company Aqilion develops drug for eosinophilic esophagitis

When Aqilion began developing a drug for eosinophilic esophagitis, the molecule was classified as an orphan drug. But the prevalence of the disease now appears ...

Non-destructive testing and assembly control

Assess complete assembly.

Genovis i samarbetsavtal med nederländsk partner

Biotechbolaget Genovis har ingått ett partnerskap med nederländska Single Cell Discoveries för att möjliggöra storskaliga analyser av genuttryck.